SETD2 and breast cancer: Elevated SETD2 expression correlated with better overall survival in all the subtypes of breast cancer (Figures 6e–h, ER-positive cases—229 high and 229 low; ER-negative cases—68 high and 67 low; HER-negative cases—135 high and 134 low).